Mogrify Ltd (Mogrify®), a UK biotechnology company aiming to transform the development of cell therapies by the systematic discovery of novel cell conversions, today announced the appointment of Lorenz Mayr, PhD, to the Board of Directors and the Scientific Advisory Board (SAB).
Mogrify will transform the development of life saving cell therapies via the licence of proprietary cell conversions tailored to any therapeutic application
Telephone: 01223 734154
25 Cambridge Science Park Milton Rd Cambridge
Post Code: CB4 0FW
Country: United Kingdom
Membership Type: Corporate 21-50